Dapagliflozin added to usual care in individuals with type 2 diabetes mellitus with preexisting cardiovascular disease: a 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension (Q88008831)
Jump to navigation
Jump to search
scientific article published on 02 June 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dapagliflozin added to usual care in individuals with type 2 diabetes mellitus with preexisting cardiovascular disease: a 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension |
scientific article published on 02 June 2014 |
Statements
Dapagliflozin added to usual care in individuals with type 2 diabetes mellitus with preexisting cardiovascular disease: a 24-week, multicenter, randomized, double-blind, placebo-controlled study with a 28-week extension (English)
Lawrence A Leiter
William T Cefalu
Tjerk W A de Bruin
Ingrid Gause-Nilsson
Jennifer Sugg
Shamik J Parikh